Clinical Trial Update: Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports results from Phase 1/2 testing carboplatin and etoposide with or without atezolizumab (MPDL3280A) as first-line therapy for untreated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Giuseppe Giaccone | Conditions: Small Cell Lung Cancer ( SCLC ) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-07-02